Evidence map›Paper›PMID 10796626›Full record

SynthesisThe Cochrane database of systematic reviews2000

Bronchodilators for bronchiolitis.

J D Kellner, A Ohlsson, A M Gadomski, E E Wang

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Saline nebulizers in treatment of bronchiolitis.Journal of family medicine and primary care · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Respiratory syncytial virus: current and emerging treatment options.ClinicoEconomics and outcomes research : CEOR · 2014
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Bronchiolitis.Canadian family physician Medecin de famille canadien · 2008
    Review
  18. Article
  19. Article
  20. Pathogenesis of respiratory syncytial virus infection in the murine model.Proceedings of the American Thoracic Society · 2005
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

J D KellnerAlberta Children's Hospital, 1820 Richmond Road SW, Calgary, Alberta, Canada, T2T 5C7. jim.kellner@crha-health.ab.ca
A Ohlsson
A M Gadomski
E E Wang
Bassett Medical Center · USInstitut Pasteur · FRRichmond Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesBronchiolitis is an acute, highly communicable lower respiratory tract infection. Bronchodilators are commonly used in the management of bronchiolitis in North America, but not in the United Kingdom. The objective of this review was to assess the effects of bronchodilators for bronchiolitis. SEARCH STRATEGY: We searched MEDLINE, EMBASE, Reference Update, reference lists of articles, and the files of two of the authors up to June 1998. SELECTION CRITERIA: Randomised trials comparing bronchodilators with placebo in the treatment of bronchiolitis. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. Unpublished data were requested from authors when necessary. MAIN

resultsIn eight trials with 394 children, 46% demonstrated an improved clinical score with bronchodilators compared to 75% with placebo (odds ratio for no improvement 0.29, 95% confidence interval 0.19 to 0.45). However, the inclusion of studies that enrolled people with recurrent wheezes may have biased these results in favour of bronchodilators. Bronchodilator recipients did not show improvement in measures of oxygenation, the rate of hospitalisation (18% versus 26%, odds ratio 0.70, 95% confidence interval 0.36 to 1.35) or duration of hospitalisation (weighted mean difference 0.12, 95% confidence interval -0.3 to 0.5). REVIEWER'S

conclusionsBronchodilators produce modest short-term improvement in clinical scores. This small benefit must be weighed against the costs of these agents.

Indexed as

BronchiolitisBronchodilator AgentsHumansBronchodilator Agents

Identifiers

PMID10796626
OpenAlexW4252109801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.